Article Versions Notes

Lasola JJM, Cottingham AL, Scotland BL, Truong N, Hong CC, Shapiro P, Pearson RM. Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK. Pharmaceutics. 2021; 13(11):1841. https://doi.org/10.3390/pharmaceutics13111841

Lasola, Jackline Joy Martín, Andrea L. Cottingham, Brianna L. Scotland, Nhu Truong, Charles C. Hong, Paul Shapiro, and Ryan M. Pearson. 2021. "Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK" Pharmaceutics 13, no. 11: 1841. https://doi.org/10.3390/pharmaceutics13111841

Lasola, J. J. M., Cottingham, A. L., Scotland, B. L., Truong, N., Hong, C. C., Shapiro, P., & Pearson, R. M. (2021). Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK. Pharmaceutics, 13(11), 1841. https://doi.org/10.3390/pharmaceutics13111841